Search Legislation

Commission Regulation (EC) No 1266/2007Show full title

Commission Regulation (EC) No 1266/2007 of 26 October 2007 on implementing rules for Council Directive 2000/75/EC as regards the control, monitoring, surveillance and restrictions on movements of certain animals of susceptible species in relation to bluetongue (Text with EEA relevance)

 Help about what version

What Version

 Help about advanced features

Advanced Features

 Help about UK-EU Regulation

Legislation originating from the EU

When the UK left the EU, legislation.gov.uk published EU legislation that had been published by the EU up to IP completion day (31 December 2020 11.00 p.m.). On legislation.gov.uk, these items of legislation are kept up-to-date with any amendments made by the UK since then.

Close

This item of legislation originated from the EU

Legislation.gov.uk publishes the UK version. EUR-Lex publishes the EU version. The EU Exit Web Archive holds a snapshot of EUR-Lex’s version from IP completion day (31 December 2020 11.00 p.m.).

Status:

Point in time view as at 04/05/2008.

Changes to legislation:

There are currently no known outstanding effects by UK legislation for Commission Regulation (EC) No 1266/2007. Help about Changes to Legislation

Close

Changes to Legislation

Revised legislation carried on this site may not be fully up to date. At the current time any known changes or effects made by subsequent legislation have been applied to the text of the legislation you are viewing by the editorial team. Please see ‘Frequently Asked Questions’ for details regarding the timescales for which new effects are identified and recorded on this site.

ANNEX IU.K.Minimum requirements for bluetongue monitoring and surveillance programmes (referred to in Article 4)

1.Minimum requirements for bluetongue monitoring programmes to be implemented by Member States in restricted zonesU.K.

Bluetongue monitoring programmes in restricted zones shall be aimed at providing information on the dynamics of bluetongue in a zone already subjected to restrictions.

The geographical unit of reference shall be defined by a grid of around 45 × 45 km (approximately 2 000 km2) unless specific environmental conditions justify a different size. In certain Member States, the ‘region’ as defined in Article 2 of Directive 64/432/EEC may be used as the geographical unit of reference for monitoring purposes.

Bluetongue monitoring programmes must consist at least of the following elements:

1.1.

Serological monitoring with sentinel animals:

  • Serological monitoring with sentinel animals shall consist of an active annual programme of testing sentinel animals aimed at assessing the circulation of bluetongue virus within the restricted zones. Where possible, sentinel animals must be bovine animals. They must be free from antibodies as demonstrated by means of a preliminary seronegative test and must be located in areas of the restricted zone where, following a risk analysis considering entomological and ecological evaluations, the presence of the vector has been confirmed or habitats suitable for the vector’s breeding are present,

  • Sentinel animals shall be tested at least every month during the period of activity of the vector involved, if known. In the absence of such information the sentinel animals shall be tested at least monthly throughout the year. However, the testing frequency may be adjusted to the seasonal variations of the epidemiological situation during the year to establish the beginning and the end of the circulation of bluetongue virus within the restricted zones,

  • The minimum number of sentinel animals per geographical unit must be representative and sufficient in order to detect a monthly incidence of seroconversion(1) of 2 % with a 95 % confidence in each geographical unit.

1.2.

Entomological monitoring

  • Entomological monitoring shall consist of an active programme of vector catching by means of permanently sited traps intended to determine the population dynamics and overwintering features of the Culicoides species in the sampled site in order to determine the seasonally vector-free period in the bluetongue seasonally-free zone in accordance with Annex V,

  • Only aspiration traps equipped with ultraviolet light shall be used in accordance with pre-established protocols. The traps must be operated throughout the night and operate at a rate of at least one night per week at least during the period of the year necessary to determine the beginning and the end of the seasonally vector free period. At least one trap must be placed in each geographical unit all over the restricted zone. The frequency of operation of the traps must be adjusted to the seasonal variations of the epidemiological situation during the year to optimise the determination of the population dynamics and overwintering features of the Culicoides and may be amended on the basis of the evidence obtained in the three first years of operation of the traps. An adequate proportion of the midges collected in the insect traps must be sent to a specialised laboratory capable of counting and identifying Culicoides species on a routine basis.

2.Minimum requirements for bluetongue surveillance programmes to be implemented by the Member States outside restricted zonesU.K.

Bluetongue surveillance programmes outside restricted zones shall be aimed at the detection of virus circulation in a bluetongue-free Member State or epidemiologically relevant geographical area and must consist at least of the following elements:

2.1.

Passive clinical surveillance:

  • shall consist of a formal and ongoing system aimed at detecting and investigating suspicions of bluetongue including an early warning system for reporting suspicious cases. Owners or holders of animals as well as veterinarians must report promptly any suspicion of bluetongue to the competent authority. All suspected cases of bluetongue must be investigated immediately,

  • must be specially reinforced during the season of vector activity, and in particular at its beginning,

  • must ensure that awareness campaigns are put in place and aimed, in particular, at enabling veterinarians and farmers in identifying clinical signs of bluetongue.

2.2.

Serological surveillance:

  • shall consist of an active annual programme of serological testing of susceptible species populations, aimed at detecting evidence of the bluetongue virus transmission through random or targeted serological and/or virological testing proportional to the risk of infection of the Member State or epidemiologically relevant geographical area and performed in the period of the year when seroconversion is more likely to be detected,

  • must be designed in such a way that the samples are representative of the bovine population in the Member State or in an epidemiologically relevant geographical area and the sample size has been calculated to detect a prevalence of 0,5 % with 95 % confidence in the bovine population of that Member State or geographical area,

  • must ensure that samples sizes are adjusted to the structure of the bovine population to be sampled and for the use of targeted surveillance, focusing the sampling for the surveillance on high-risk populations in which specific commonly known risk factors exist. The design of the targeted surveillance must ensure that seropositive animals from vaccinated or immunised populations referred to in points 5, 6 and 7 of Part A of Annex III do not interfere with the bluetongue surveillance programme.

2.3.

Entomological surveillance:

  • shall consist of an active annual programme of vector catching aimed at gathering information on the proven and potential vector species in the Member State or in an epidemiologically relevant geographical area, their distribution and seasonal profiles,

  • shall be implemented in all Member States where information on the proven and potential vector species, their distribution and seasonal profiles in the Member State is lacking.

ANNEX IIU.K.Information to be transmitted by the Member States to the BT-Net system (referred to in Article 5(2))

The information to be transmitted by the Member States to the BT-Net system shall include at least the following:

1.Bluetongue serological/virological dataU.K.

(a)

Administrative division/unit

(b)

Animal species tested

(c)

Type of surveillance system scheme (sentinel system or periodical survey)

(d)

Type of diagnostic tests performed (ELISA, Serum-neutralisation, PCR, virus isolation)

(e)

Month and year

(f)

Number of tested animals(2)

(g)

Number of positive animals

(h)

Serotype serologically or virologically determined (data to be provided in case of positive results to serum-neutralization or virus isolation tests)

2.Bluetongue entomological dataU.K.

(a)

Administrative division

(b)

Site unique identity (a unique code for each trapping site)

(c)

Collection date

(d)

Latitude and longitude

(e)

Total number of Culicoides spp. collected

(f)

Number of C. imicola collected, if available

(g)

Number of C. obsoletus Complex collected, if available

(h)

Number of C. obsoletus sensu strictu collected, if available

(i)

Number of C. scoticus collected, if available

(j)

Number of C. Pulicaris Complex collected, if available

(k)

Number of C. Nubeculosus complex collected, if available

(l)

Number of C. dewulfii collected, if available

(m)

Other relevant data

3.Bluetongue vaccination dataU.K.

(a)

Administrative division

(b)

Year/semester

(c)

Type of vaccine

(d)

Serotype combination

(e)

Animal species vaccinated

(f)

Total number of herds in the Member State

(g)

Total number of animals in the Member State

(h)

Total number of herds under the vaccination programme

(i)

Total number of animals under the vaccination programme

(j)

Total number of herds vaccinated

(k)

Number of animals vaccinated (where the vaccination type is vaccination of young animals)

(l)

Number of young animals vaccinated (where the vaccination type is mass vaccination)

(m)

Number of adults vaccinated (where the vaccination type is mass vaccination)

(n)

Doses of vaccine administered.

[F1ANNEX III U.K. Conditions for exemption from the exit ban (referred to in Articles 7(2)(a) and 8(1)(a))

A. Animals U.K.

The animals must have been protected against attacks by vector Culicoides during transportation to the place of destination.

In addition, at least one of the conditions set out in points 1 to 7 must be complied with:

1.

[F2The animals were kept until dispatch during the seasonally vector-free period defined in accordance with Annex V, in a bluetongue seasonally-free zone for at least 60 days prior to the date of movement and were subjected to an agent identification test according to the Manual of Diagnostic Tests and Vaccines for Terrestrial Animals of the World Organisation for Animal Health (OIE) (3) (OIE Terrestrial Manual), with negative results, carried out not earlier than seven days before the date of movement.]

However, that agent identification test shall not be necessary for Member States or regions of a Member State where sufficient epidemiological data, obtained following the implementation of a monitoring programme for a period of not less than three years, substantiate the determination of the seasonally vector-free period defined in accordance with Annex V.

The Member States making use of that possibility shall inform the Commission and the other Member States in the framework of the Standing Committee on the Food Chain and Animal Health.

Where animals referred to in this point are intended for intra-Community trade or export to a third country, the following additional wording shall be added to the corresponding health certificates laid down in Directives 64/432/EEC, 91/68/EEC and 92/65/EEC, or referred to in Decision 93/444/EEC:

Animal(s) were kept until dispatch in a bluetongue seasonally-free zone during the seasonally vector-free period that started on … ( insert date ) since birth or for at least 60 days and, if appropriate ( indicate as appropriate ), were then subjected to an agent identification test according to the OIE Terestrial Manual on samples taken within seven days prior to dispatch, with negative results, in conformity with Annex III.A(1) to Regulation (EC) No 1266/2007.

2.

The animals have been kept until dispatch protected against attacks by vectors for a period of at least 60 days prior to the date of dispatch.

Where animals referred to in this point are intended for intra-Community trade or export to a third country, the following additional wording shall be added to the corresponding health certificates laid down in Directives 64/432/EEC, 91/68/EEC and 92/65/EEC, or referred to in Decision 93/444/EEC:

Animal(s) in conformity with Annex III.A(2) to Regulation (EC) No 1266/2007.

3.

The animals have been kept until dispatch in a bluetongue seasonally-free zone during the seasonally vector-free period, defined in accordance with Annex V, or have been protected against attacks by vectors for a period of at least 28 days and were subjected during that period to a serological test according to the OIE Terrestrial Manual to detect antibodies to the bluetongue virus group, with negative results, carried out at least 28 days following the date of the commencement of the period of protection against attacks by vectors or the seasonally vector-free period.

Where animals referred to in this point are intended for intra-Community trade or export to a third country, the following additional wording shall be added to the corresponding health certificates laid down in Directives 64/432/EEC, 91/68/EEC and 92/65/EEC, or referred to in Decision 93/444/EEC:

Animal(s) in conformity with Annex III.A(3) to Regulation (EC) No 1266/2007.

4.

The animals have been kept until dispatch in a bluetongue seasonally-free zone during the seasonally vector-free period, defined in accordance with Annex V, or have been protected against attacks by vectors for a period of at least 14 days and were subjected during that period to an agent identification test according to the OIE Terrestrial Manual, with negative results, carried out at least 14 days following the date of the commencement of the period of protection against attacks by vectors or the seasonally vector-free period.

Where animals referred to in this point are intended for intra-Community trade or export to a third country, the following additional wording shall be added to the corresponding health certificates laid down in Directives 64/432/EEC, 91/68/EEC and 92/65/EEC, or referred to in Decision 93/444/EEC:

Animal(s) in conformity with Annex III.A(4) to Regulation (EC) No 1266/2007.

5.

The animals originate from a herd vaccinated according to a vaccination programme adopted by the competent authority and the animals have been vaccinated against the serotype(s) present or likely to be present in an epidemiologically relevant geographical area of origin, the animals are still within the immunity period of time guaranteed in the specifications of the vaccine approved in the vaccination programme and the animals meet at least one of the following requirements:

(a)

they have been vaccinated more than 60 days before the date of movement;

(b)

they have been vaccinated with an inactivated vaccine before at least the number of days necessary for the onset of the immunity protection set in the specifications of the vaccine approved in the vaccination programme and were subjected to an agent identification test according to the OIE Terrestrial Manual, with negative results, carried out at least 14 days after the onset of the immunity protection set in the specifications of the vaccine approved in the vaccination programme;

(c)

they were previously vaccinated and they have been re-vaccinated with an inactivated vaccine within the immunity period of time guaranteed in the specifications of the vaccine approved in the vaccination programme;

(d)

they were kept during the seasonally vector-free period, defined in accordance with Annex V, in a bluetongue seasonally-free zone, since birth or for a period of at least 60 days before the date of vaccination and have been vaccinated with an inactivated vaccine before at least the number of days necessary for the onset of the immunity protection set in the specifications of the vaccine approved in the vaccination programme.

Where animals referred to in this point are intended for intra-Community trade or export to a third country, the following additional wording shall be added to the corresponding health certificates laid down in Directives 64/432/EEC, 91/68/EEC and 92/65/EEC, or referred to in Decision 93/444/EEC:

Animal(s) vaccinated against bluetongue serotype/s … ( insert serotype/s ) with … ( insert name of the vaccine ) with a inactivated/modified live vaccine ( indicate, as appropriate ) in conformity with Annex III.A(5) to Regulation (EC) No 1266/2007.

6.

The animals have never been vaccinated against bluetongue and were always kept in an epidemiologically relevant geographical area of origin where not more than one serotype was or is present or likely to be present and:

(a)

[F3they were subjected to two serological tests according to the OIE Terrestrial Manual to detect antibodies against the bluetongue virus serotype, with positive results; the first test being carried out on samples taken between 60 and 360 days before the date of movement and the second test being carried out on samples taken not earlier than seven days before the date of the movement; or]

(b)

they were subjected to a serological test according to the OIE Terrestrial Manual to detect antibodies against the bluetongue virus serotype, with positive results; the test must be carried out at least 30 days before the date of the movement and the animals were subjected to an agent identification test according to the OIE Terrestrial Manual, with negative results, carried out not earlier than seven days before the date of the movement.

Where animals referred to in this point are intended for intra-Community trade or export to a third country, the following additional wording shall be added to the corresponding health certificates laid down in Directives 64/432/EEC, 91/68/EEC and 92/65/EEC, or referred to in Decision 93/444/EEC:

Animal(s) subjected to a serological test according to the OIE Terrestrial Manual to detect antibodies against the bluetongue virus serotype … ( indicate serotype ) in conformity with Annex III.A(6) to Regulation (EC) No 1266/2007.

7.

[F3The animals have never been vaccinated against the bluetongue virus and were subjected with positive results to two adequate serological tests according to the OIE Terrestrial Manual able to detect specific antibodies against all the bluetongue virus serotypes present or likely to be present, in the epidemiologically relevant geographical area of origin, and:

(a)

the first test must have been carried out on samples that were taken between 60 and 360 days before the date of movement and the second test must have been carried out on samples that were taken not earlier than seven days before the date of movement; or]

(b)

the specific serotype serological test is carried out at least 30 days before the date of the movement and the animals were subjected to an agent identification test according to the OIE Terrestrial Manual, with negative results, carried out not earlier than seven days before the date of movement.

Where animals referred to in this point are intended for intra-Community trade or export to a third country, the following additional wording shall be added to the corresponding health certificates laid down in Directives 64/432/EEC, 91/68/EEC and 92/65/EEC, or referred to in Decision 93/444/EEC:

Animal(s) subjected to a specific serological test according to the OIE Terrestrial Manual to detect antibodies against all the bluetongue virus serotypes … ( indicate serotypes ) present or likely to be present in conformity with Annex III.A(7) to Regulation (EC) No 1266/2007.

[F4For pregnant animals, at least one of the conditions set out in points 5(b), 5(c), 5(d), 6 and 7 must be complied with before insemination or mating, or the condition set out in point 3 is complied with, the test being carried out not earlier than seven days before the date of movement.

Where animals are intended for intra-Community trade or export to a third country, one of the following additional wordings shall be added as appropriate to the corresponding health certificates laid down in Directives 64/432/EEC, 91/68/EEC and 92/65/EEC, or referred to in Decision 93/444/EEC if applicable:

Animal(s) is (are) not pregnant , or

Animal(s) may be pregnant and complies (comply) with the condition(s) … (set out in points 5(b), 5(c), 5(d), 6 and 7 before insemination or mating, or set out in point 3; indicate as appropriate) .]

B. Semen of animals U.K.

Semen must have been obtained from donor animals which comply with at least one of the following conditions:

(a)

they have been kept outside a restricted zone for a period of at least 60 days before commencement of, and during, collection of the semen;

(b)

they have been protected against attacks by vectors for a period of at least 60 days before commencement of, and during, collection of the semen;

(c)

they were kept during the seasonally vector-free period in a bluetongue seasonally-free zone, defined in accordance with Annex V, for a period of at least 60 days before commencement of, and during, collection of the semen and were subjected to an agent identification test according to the OIE Terrestrial Manual, with negative results, carried out not earlier than seven days before the date of commencement of collection of the semen.

However, that agent identification test shall not be necessary in Member States or regions of a Member State where sufficient epidemiological data, obtained following the implementation of a monitoring programme during a period of not less than three years, substantiate the determination of the seasonally vector-free period, as defined in Annex V.

The Member States making use of that possibility shall inform the Commission and the Member States in the framework of the Standing Committee on the Food Chain and Animal Health;

(d)

they have been subjected to a serological test according to the OIE Terrestrial Manual to detect antibodies to the bluetongue virus group, with negative results, at least every 60 days during the collection period and between 21 and 60 days following the final collection;

(e)

they have been subjected, with negative results, to an agent identification test according to the OIE Terrestrial Manual carried out on blood samples collected:

(i)

at commencement and final collection; and

(ii)

during the period of semen collection:

  • at least every seven days, in the case of a virus isolation test,

  • at least every 28 days, in the case of a polymerase chain reaction test.

Where the semen referred to in this Section is intended for intra-Community trade or export to a third country, the following additional wording shall be added to the corresponding health certificates laid down in Council Directive 88/407/EEC (4) and Commission Decision 95/388/EC (5) , or referred to in Decision 93/444/EEC:

Semen obtained from donor animals which comply with … ( point (a), (b), (c), (d) or (e), indicate as appropriate ) of Annex III.B to Regulation (EC) No 1266/2007 .

C. Ova and embryos of animals U.K.

1. In vivo derived embryos and ova of bovine animals must have been obtained from donor animals which do not show any clinical signs of bluetongue on the day of collection. U.K.

2. Embryos and ova of animals other than bovine animals and in vitro produced bovine embryos must have been obtained from donor animals which comply with at least one of the following conditions: U.K.

(a)

they have been kept outside a restricted zone for at least 60 days before commencement of, and during, collection of the embryos/ova;

(b)

they have been protected against attacks by vectors for at least 60 days before commencement of, and during, collection of the embryos/ova;

(c)

they have been subjected to a serological test according to the OIE Terrestrial Manual to detect antibodies to the bluetongue virus group, between 21 and 60 days following collection of the embryos/ova, with negative results;

(d)

they have been subjected to an agent identification test according to the OIE Terrestrial Manual on a blood sample taken on the day of collection of the embryos/ova, with negative results.

3. Where the ova and embryos referred to in points 1 and 2 are intended for intra-Community trade or export to a third country, the following additional wording shall be added to the corresponding health certificates laid down in Council Directive 89/556/EEC (6) and Decision 95/388/EC, or referred to in Decision 93/444/EEC: U.K.

Embryos/ova obtained from donor animals which comply with … (point 1; point 2(a), point 2(b), point 2(c) or point 2(d), indicate as appropriate) of Annex III.C to Regulation (EC) No 1266/2007 .

Point 2(a) of Annex B to Directive 89/556/EEC shall not apply to ova and embryos collected from donor animals kept in holdings subject to veterinary prohibition or quarantine measures pertaining to bluetongue.]

ANNEX IVU.K.Criteria for the designation of slaughterhouses for exemption from the exit ban (referred to in the second paragraph of Article 8(4))

For the purpose of the risk assessment for the designation of slaughterhouses for the channelling of movements of animals from a holding located in a restricted zone for immediate slaughter, the competent authority of destination shall use at least the following criteria:

1.

the data available through the monitoring and surveillance programmes, especially as regards the vector’s activity;

2.

the distance from the point of entry in the non-restricted zone to the slaughterhouse;

3.

the entomological data on the route;

4.

the period of the day during which the transport takes place in relation to the hours of activity of the vectors;

5.

the possible use of insecticides and repellents in compliance with Council Directive 96/23/EC(7);

6.

the location of the slaughterhouse as regards livestock holdings;

7.

the biosecurity measures in place at the slaughterhouse.

ANNEX VU.K.Criteria for the definition of the seasonally vector-free period (referred to in Article 9(3))

For the purpose of determining a bluetongue seasonally-free zone, the seasonally vector-free period for a determinate epidemiologically relevant geographical area of a Member State (epidemiologically relevant geographical area) shall be defined by the competent authority using at least the following criteria:

1.General criteriaU.K.

(a)A bluetongue monitoring and/or surveillance programme must be in place.U.K.

(b)The specific criteria and thresholds used for the determination of the seasonally vector-free period shall be defined considering the Culicoides species proven or suspected to be the main vectors in the epidemiologically relevant geographical area.U.K.

(c)The criteria used for the determination of the seasonal vector-free period shall be applied considering data from current and previous years (historical data). In addition, the aspects linked to surveillance data standardization shall be taken into consideration.U.K.

2.Specific criteriaU.K.

(a)No bluetongue virus circulation within the epidemiologically relevant geographical area, as demonstrated by bluetongue surveillance programmes or other evidence suggesting a halt in bluetongue virus.U.K.

(b)Cessation of vector and likely vector activity, as demonstrated through entomological surveillance as part of the bluetongue monitoring and/or surveillance programmes.U.K.

(c)Captures of Culicoides species proven or suspected to be the vectors of the serotype present in the epidemiologically relevant geographical area below a maximum threshold of vectors collected that shall be defined for the epidemiologically relevant geographical area. In the absence of sound evidence supporting the determination of the maximum threshold, total absence of Culicoides imicola specimens and less than five parous Culicoides per trap must be used.U.K.

3.Additional criteriaU.K.

(a)Temperature conditions that impact on the behaviour of the vectors activity for the epidemiologically relevant geographical area. The temperature thresholds shall be defined in consideration of the ecological behaviour of Culicoides species proven or suspected to be the vectors of the serotype present in the epidemiologically relevant geographical area.U.K.

(1)

It has been estimated that 20 % is the normal annual rate of seroconversion in an infected zone. However, in the Community, virus circulation mainly takes place in a period of around six months (end of spring/mid autumn). Therefore 2 % is a conservative estimation of the expected monthly rate of seroconversion.

(2)

If pools of sera are used, an estimation of the number of animals corresponding to the pools tested must be reported.

(3)

[F1 [F2http://www.oie.int/eng/normes/en_mcode.htm?e1d10] ]

(7)

OJ L 125, 23.5.1996, p. 10. Directive as last amended by Directive 2006/104/EC.

Back to top

Options/Help

Print Options

Close

Legislation is available in different versions:

Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.

Original (As adopted by EU): The original version of the legislation as it stood when it was first adopted in the EU. No changes have been applied to the text.

Point in Time: This becomes available after navigating to view revised legislation as it stood at a certain point in time via Advanced Features > Show Timeline of Changes or via a point in time advanced search.

Close

See additional information alongside the content

Geographical Extent: Indicates the geographical area that this provision applies to. For further information see ‘Frequently Asked Questions’.

Show Timeline of Changes: See how this legislation has or could change over time. Turning this feature on will show extra navigation options to go to these specific points in time. Return to the latest available version by using the controls above in the What Version box.

Close

Opening Options

Different options to open legislation in order to view more content on screen at once

Close

More Resources

Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as adopted version that was used for the EU Official Journal
  • lists of changes made by and/or affecting this legislation item
  • all formats of all associated documents
  • correction slips
  • links to related legislation and further information resources
Close

Timeline of Changes

This timeline shows the different versions taken from EUR-Lex before exit day and during the implementation period as well as any subsequent versions created after the implementation period as a result of changes made by UK legislation.

The dates for the EU versions are taken from the document dates on EUR-Lex and may not always coincide with when the changes came into force for the document.

For any versions created after the implementation period as a result of changes made by UK legislation the date will coincide with the earliest date on which the change (e.g an insertion, a repeal or a substitution) that was applied came into force. For further information see our guide to revised legislation on Understanding Legislation.

Close

More Resources

Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as adopted version that was used for the print copy
  • correction slips

Click 'View More' or select 'More Resources' tab for additional information including:

  • lists of changes made by and/or affecting this legislation item
  • confers power and blanket amendment details
  • all formats of all associated documents
  • links to related legislation and further information resources